Therapy Areas: Inflammatory Diseases
26 September 2022 - - Iceland-based clinical-stage biopharmaceutical company EpiEndo Pharmaceuticals has received regulatory and ethics approval to commence a Lipopolysaccharide challenge clinical tri...
26 September 2022 - - US-based clinical-stage immunotherapy company Alpine Immune Sciences, Inc. (NASDAQ: ALPN) will host an R and D Day featuring clinical data presentations on ALPN-303, a potentiall...
23 September 2022 - - An article in Nature Communications shows translational results from preclinical animal models to an exploratory, placebo-controlled clinical trial of neflama...
23 September 2022 - Pharmaceutical company AstraZeneca plc (STO:AZN) (LON:AZN) (Nasdaq:AZN) announced on Friday that Ultomiris (ravulizumab) has been approved by European regulators as an add-on to st...
23 September 2022 - People Science, a US-based direct-to-consumer scientific research company providing a scaled R&D platform for alternative medicines, and Sen-Jam Pharmaceutical, a US-based drug...
22 September 2022 - - US-based biotechnology company Immunis Inc has initiated patient enrollment for their Phase 1/2a clinical trial to assess Immunis' immunomodulatory secretome produ...